RE:RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pelajimsenior - the abstract demonstrated the benefit of a dual-specific (DS) CAR-T that was comprised of an OV (reovirus) and EGFRvIII CAR-T cells which was a novel and effective delivery system that was further enhanced by a systemic boost with reovirus which when given alone for a second time, the "boost" rapidly reactived (DS) CAR-T cells against tumors and resulted in long-term cures.